Suppr超能文献

靶向肾脏疾病中的能量通路:去乙酰化酶、AMPK 和 PGC1α 的作用。

Targeting energy pathways in kidney disease: the roles of sirtuins, AMPK, and PGC1α.

机构信息

Division of Nephrology, Boston Children's Hospital, Boston, Massachusetts, USA; Harvard Medical School, Boston, Massachusetts, USA.

Harvard Medical School, Boston, Massachusetts, USA; Division of Nephrology and Center for Vascular Biology Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.

出版信息

Kidney Int. 2021 Apr;99(4):828-840. doi: 10.1016/j.kint.2020.09.037. Epub 2020 Dec 8.

Abstract

The kidney has extraordinary metabolic demands to sustain the active transport of solutes that is critical to renal filtration and clearance. Mitochondrial health is vital to meet those demands and maintain renal fitness. Decades of studies have linked poor mitochondrial health to kidney disease. Key regulators of mitochondrial health-adenosine monophosphate kinase, sirtuins, and peroxisome proliferator-activated receptor γ coactivator-1α-have all been shown to play significant roles in renal resilience against disease. This review will summarize the latest research into the activities of those regulators and evaluate the roles and therapeutic potential of targeting those regulators in acute kidney injury, glomerular kidney disease, and renal fibrosis.

摘要

肾脏具有非凡的代谢需求,以维持溶质的主动转运,这对肾脏过滤和清除至关重要。线粒体健康对于满足这些需求和维持肾脏健康至关重要。数十年来的研究将线粒体健康不良与肾脏疾病联系起来。线粒体健康的关键调节剂——腺苷单磷酸激酶、沉默调节蛋白和过氧化物酶体增殖物激活受体 γ 共激活因子 1α——都已被证明在肾脏对疾病的抵抗力中发挥着重要作用。本综述将总结这些调节剂活性的最新研究,并评估靶向这些调节剂在急性肾损伤、肾小球肾病和肾纤维化中的作用和治疗潜力。

相似文献

1
Targeting energy pathways in kidney disease: the roles of sirtuins, AMPK, and PGC1α.
Kidney Int. 2021 Apr;99(4):828-840. doi: 10.1016/j.kint.2020.09.037. Epub 2020 Dec 8.
3
Klotho ameliorates diabetic nephropathy via LKB1-AMPK-PGC1α-mediated renal mitochondrial protection.
Biochem Biophys Res Commun. 2021 Jan 1;534:1040-1046. doi: 10.1016/j.bbrc.2020.10.040. Epub 2020 Oct 26.
7
PGC-1α ameliorates kidney fibrosis in mice with diabetic kidney disease through an antioxidative mechanism.
Mol Med Rep. 2018 Mar;17(3):4490-4498. doi: 10.3892/mmr.2018.8433. Epub 2018 Jan 16.
10
The Role of PGC-1α and Mitochondrial Biogenesis in Kidney Diseases.
Biomolecules. 2020 Feb 24;10(2):347. doi: 10.3390/biom10020347.

引用本文的文献

1
The Ketogenic Diet in Obesity Management: Friend or Foe?
Cell Biochem Biophys. 2025 Aug 29. doi: 10.1007/s12013-025-01878-0.
6
Effect of dexpanthenol on glycerol-induced acute kidney injury by targeting the PGC-1α/SIRT3 pathway.
Naunyn Schmiedebergs Arch Pharmacol. 2025 Mar 25. doi: 10.1007/s00210-025-04071-5.
9
Exploring the role and therapeutic potential of lipid metabolism in acute kidney injury.
Ren Fail. 2024 Dec;46(2):2403652. doi: 10.1080/0886022X.2024.2403652. Epub 2024 Sep 25.
10
See the power in kidney cells with ATP biosensor.
Kidney Int. 2024 Sep;106(3):362-364. doi: 10.1016/j.kint.2024.06.019.

本文引用的文献

1
SGLT2 Inhibition Mediates Protection from Diabetic Kidney Disease by Promoting Ketone Body-Induced mTORC1 Inhibition.
Cell Metab. 2020 Sep 1;32(3):404-419.e6. doi: 10.1016/j.cmet.2020.06.020. Epub 2020 Jul 28.
4
Resveratrol improves lipid metabolism in diabetic nephropathy rats.
Front Biosci (Landmark Ed). 2020 Jun 1;25(10):1913-1924. doi: 10.2741/4885.
7
NAD deficiency due to environmental factors or gene-environment interactions causes congenital malformations and miscarriage in mice.
Proc Natl Acad Sci U S A. 2020 Feb 18;117(7):3738-3747. doi: 10.1073/pnas.1916588117. Epub 2020 Feb 3.
8
9
Bi-allelic Mutations in NADSYN1 Cause Multiple Organ Defects and Expand the Genotypic Spectrum of Congenital NAD Deficiency Disorders.
Am J Hum Genet. 2020 Jan 2;106(1):129-136. doi: 10.1016/j.ajhg.2019.12.006. Epub 2019 Dec 26.
10
Sirt5 Attenuates Cisplatin-Induced Acute Kidney Injury through Regulation of Nrf2/HO-1 and Bcl-2.
Biomed Res Int. 2019 Nov 14;2019:4745132. doi: 10.1155/2019/4745132. eCollection 2019.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验